Pfizer, Inc. Stock price

Equities

PFE

US7170811035

Pharmaceuticals

Market Closed - Nyse 04:00:12 2024-03-27 pm EDT 5-day change 1st Jan Change
27.78 USD +0.69% Intraday chart for Pfizer, Inc. +0.29% -3.51%
Sales 2024 * 59.91B Sales 2025 * 63B Capitalization 157B
Net income 2024 * 7.81B Net income 2025 * 12.7B EV / Sales 2024 * 3.39 x
Net Debt 2024 * 45.61B Net Debt 2025 * 42.35B EV / Sales 2025 * 3.17 x
P/E ratio 2024 *
18.5 x
P/E ratio 2025 *
12.2 x
Employees 88,000
Yield 2024 *
6.13%
Yield 2025 *
6.29%
Free-Float 59.09%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.07%
1 week+0.29%
Current month+4.59%
1 month+3.31%
3 months-2.90%
6 months-13.46%
Current year-3.51%
More quotes
1 week
27.10
Extreme 27.1
27.94
1 month
25.61
Extreme 25.61
28.69
Current year
25.61
Extreme 25.61
30.28
1 year
25.61
Extreme 25.61
42.22
3 years
25.61
Extreme 25.61
61.71
5 years
25.61
Extreme 25.61
61.71
10 years
25.61
Extreme 25.61
61.71
More quotes
Managers TitleAgeSince
Chief Executive Officer 62 92-12-31
Director of Finance/CFO 59 22-05-01
Chief Tech/Sci/R&D Officer - 19-06-30
Members of the board TitleAgeSince
Director/Board Member 66 20-03-31
Director/Board Member 64 17-02-22
Director/Board Member 60 13-09-26
More insiders
Date Price Change Volume
24-03-27 27.78 +0.69% 34,247,616
24-03-26 27.59 +0.58% 38,220,263
24-03-25 27.43 +0.26% 31,110,645
24-03-22 27.36 -1.08% 28,830,115
24-03-21 27.66 -0.14% 29,633,710

Delayed Quote Nyse, March 27, 2024 at 04:00 pm EDT

More quotes
Pfizer, Inc. is the world's leading pharmaceutical group. Net sales break down by family of products as follows: - primary care products (72.8%): medicines used in internal medicine, vaccines, medicines for the prevention and treatment of Covid-19, antivirals, mRNA-based products, etc.; - specialty care products (13.8%): medicines used in immunology, in hospitals and for the treatment of rare diseases, anti-inflammatory medicines, etc.; - oncology products (12.1%); - other (1.3%). At the end of 2022, the group had more than 35 manufacturing sites worldwide. Net sales are distributed geographically as follows: the United States (42.3%), Europe (21.9%) and other (35.8%).
Calendar
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
25
Last Close Price
27.78 USD
Average target price
32.7 USD
Spread / Average Target
+17.72%
Consensus
  1. Stock
  2. Equities
  3. Stock Pfizer, Inc. - Nyse